Pengcheng Ou

736 total citations · 1 hit paper
10 papers, 450 citations indexed

About

Pengcheng Ou is a scholar working on Epidemiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Pengcheng Ou has authored 10 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Pengcheng Ou's work include Liver Disease Diagnosis and Treatment (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and MicroRNA in disease regulation (2 papers). Pengcheng Ou is often cited by papers focused on Liver Disease Diagnosis and Treatment (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and MicroRNA in disease regulation (2 papers). Pengcheng Ou collaborates with scholars based in China, United States and Hong Kong. Pengcheng Ou's co-authors include Jun Chen, Deliang Huang, Yiming Zhang, Hong Yu, Yinan Su, Qing He, Lei Liu, Zhenghua Ma, Yang Fu and Zhiwei Li and has published in prestigious journals such as Allergy, Current Pharmaceutical Design and Molecular and Cellular Biochemistry.

In The Last Decade

Pengcheng Ou

10 papers receiving 442 citations

Hit Papers

COVID‐19 in a designated infectious diseases hospital out... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pengcheng Ou China 6 344 185 90 86 52 10 450
Zhenghua Ma China 8 397 1.2× 254 1.4× 77 0.9× 86 1.0× 21 0.4× 15 481
Meaghan Phipps United States 9 422 1.2× 195 1.1× 174 1.9× 68 0.8× 32 0.6× 17 611
Jiangshan Lian China 10 255 0.7× 163 0.9× 125 1.4× 79 0.9× 20 0.4× 35 505
Ina Jeong South Korea 11 302 0.9× 70 0.4× 92 1.0× 35 0.4× 51 1.0× 33 507
Jingmao Yang China 5 592 1.7× 279 1.5× 225 2.5× 74 0.9× 61 1.2× 7 704
Hongzhou Lu China 6 265 0.8× 112 0.6× 62 0.7× 57 0.7× 16 0.3× 11 423
Radhika Venugopal India 5 278 0.8× 128 0.7× 121 1.3× 39 0.5× 41 0.8× 8 477
Danping Liu China 8 482 1.4× 218 1.2× 159 1.8× 37 0.4× 25 0.5× 19 679
Xinguo Zhao China 7 451 1.3× 206 1.1× 86 1.0× 126 1.5× 10 0.2× 11 599

Countries citing papers authored by Pengcheng Ou

Since Specialization
Citations

This map shows the geographic impact of Pengcheng Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengcheng Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengcheng Ou more than expected).

Fields of papers citing papers by Pengcheng Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengcheng Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengcheng Ou. The network helps show where Pengcheng Ou may publish in the future.

Co-authorship network of co-authors of Pengcheng Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Pengcheng Ou. A scholar is included among the top collaborators of Pengcheng Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengcheng Ou. Pengcheng Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Zhou, Ling, Weihao Liang, Cheng Xiao, et al.. (2025). Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement. Liver International. 45(4). e16241–e16241. 1 indexed citations
2.
Wu, Weigang, et al.. (2022). Discussion on treatment courses of brucellosis with spondylitis - a report of two cases. IDCases. 31. e01650–e01650. 3 indexed citations
4.
Yang, Zhi, et al.. (2021). Efficacy of miR-122 Nanoparticle Drug Delivery System on the Patients with Drug-Induced Liver Injury. Science of Advanced Materials. 13(11). 2109–2115. 1 indexed citations
5.
Cai, Qingxian, Deliang Huang, Pengcheng Ou, et al.. (2020). COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 75(7). 1742–1752. 372 indexed citations breakdown →
6.
Yang, Zhi, Weigang Wu, Pengcheng Ou, et al.. (2020). MiR-122-5p knockdown protects against APAP-mediated liver injury through up-regulating NDRG3. Molecular and Cellular Biochemistry. 476(2). 1257–1267. 16 indexed citations
7.
Ou, Pengcheng, Hong Yu, Zhibin Zhu, et al.. (2020). 2019-nCoV Pneumonia in a Normal Work Infectious Diseases Hospital Besides Hubei Province, China. SSRN Electronic Journal. 11 indexed citations
8.
Ou, Pengcheng, Xinyu Liu, Zhiqun Tang, et al.. (2019). Gynura Segetum Related Hepatic Sinusoidal Obstruction Syndrome: A Liver Disease with High Mortality and Misdiagnosis Rate. Current Pharmaceutical Design. 25(35). 3762–3768. 8 indexed citations
9.
Ou, Pengcheng, Zhixiong Fang, & Jun Chen. (2016). Hepatitis B reactivation in a chronic hepatitis C patient treated with ledipasvir and sofosbuvir: A case report. Clinics and Research in Hepatology and Gastroenterology. 41(2). e17–e18. 9 indexed citations
10.
Ou, Pengcheng, Yi Chen, Min Zhang, et al.. (2015). Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital. SpringerPlus. 4(1). 802–802. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026